Vicarious Surgical (NYSE:RBOT) Announces Quarterly Earnings Results, Beats Estimates By $0.46 EPS

Vicarious Surgical (NYSE:RBOT) released its quarterly earnings results on Wednesday. The company reported ($1.91) earnings per share for the quarter, topping analysts’ consensus estimates of ($2.37) by $0.46, Zacks reports.

Vicarious Surgical Stock Down 9.7%

Shares of RBOT traded down $0.45 during midday trading on Wednesday, hitting $4.13. The company had a trading volume of 119,348 shares, compared to its average volume of 42,614. The stock has a market cap of $24.54 million, a price-to-earnings ratio of -0.41 and a beta of 1.41. The company’s 50 day moving average price is $5.74 and its 200 day moving average price is $7.29. Vicarious Surgical has a 52 week low of $4.04 and a 52 week high of $19.00.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on RBOT shares. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Vicarious Surgical in a report on Wednesday, October 8th. Piper Sandler lowered their target price on Vicarious Surgical from $8.50 to $7.00 and set a “neutral” rating for the company in a research note on Wednesday, August 13th. Finally, Wall Street Zen upgraded Vicarious Surgical to a “sell” rating in a research note on Saturday, September 13th. One research analyst has rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Reduce” and a consensus price target of $7.00.

Hedge Funds Weigh In On Vicarious Surgical

An institutional investor recently raised its position in Vicarious Surgical stock. Dimensional Fund Advisors LP raised its stake in shares of Vicarious Surgical Inc. (NYSE:RBOT) by 22.1% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 19,975 shares of the company’s stock after buying an additional 3,615 shares during the period. Dimensional Fund Advisors LP owned approximately 0.34% of Vicarious Surgical worth $110,000 as of its most recent SEC filing. 47.27% of the stock is owned by institutional investors.

About Vicarious Surgical

Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.